Table 1 Clinicopathological characteristics of 60 cases of CEMIP expression by immunohistochemistry.
Variable | n | CEMIP | p value | |
|---|---|---|---|---|
High (n = 43) | Low (n = 17) | |||
Age (y) | ||||
<65 (median) | 26 | 17 | 9 | 0.3955 |
≥65 | 34 | 26 | 8 | |
PSA (ng/ml) | ||||
<10 | 5 | 2 | 3 | 0.1719 |
10–20 | 21 | 15 | 6 | |
>20 | 34 | 27 | 7 | |
Gleason score | ||||
≤6 | 6 | 4 | 2 | 0.0958 |
7 | 32 | 21 | 11 | |
≥8 | 22 | 20 | 2 | |
Pathological T category | ||||
pT1/2 | 30 | 18 | 12 | 0.5889 |
pT3/4 | 30 | 21 | 9 | |
Lymph node metastasis | ||||
N0 | 50 | 36 | 14 | 0.7255 |
N1 | 10 | 7 | 3 | |
Stage classification | ||||
I–II | 23 | 11 | 12 | 0.0025 |
III–IV | 37 | 32 | 5 | |
